Lipoprotein(a) screening in patients with premature myocardial infarction: Clinical role and impact on decision-making

MLA

Mario Crisci, et al. “Lipoprotein(a) Screening in Patients with Premature Myocardial Infarction: Clinical Role and Impact on Decision-Making.” Atherosclerosis, vol. 275, Aug. 2018, p. e161. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2018.06.484.

APA

Mario Crisci, Renatomaria Bianchi, Arturo Cesaro, A. Scarda, Francesco Natale, Paolo Calabrò, A. Shatri, Fabio Fimiani, P. Limongelli, C. Annoiato, R. Calabro, Felice Gragnano, & Simona Sperlongano. (2018). Lipoprotein(a) screening in patients with premature myocardial infarction: Clinical role and impact on decision-making. Atherosclerosis, 275, e161. https://doi.org/10.1016/j.atherosclerosis.2018.06.484

Chicago

Mario Crisci, Renatomaria Bianchi, Arturo Cesaro, A. Scarda, Francesco Natale, Paolo Calabrò, A. Shatri, et al. 2018. “Lipoprotein(a) Screening in Patients with Premature Myocardial Infarction: Clinical Role and Impact on Decision-Making.” Atherosclerosis 275 (August): e161. doi:10.1016/j.atherosclerosis.2018.06.484.